Business · 29/06/2012Updated: 10/17/2026 · 1 min read
FDA Withdraws Compliance Policy Guide for Blood Banks and Firms Collecting, Manufacturing, or Processing Human Blood
Summary
The Food and Drug Administration (FDA) is withdrawing the compliance policy guide (CPG) for blood banks and firms involved in collecting, manufacturing, or processing human blood products, which was published on June 17, 1974
Original source language: Federal Register — Food and Drug AdministrationOpen original release →